Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

751
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
751
Tissue Transplantation01:24

Tissue Transplantation

818
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
818
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.1K
Overview
83.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Integrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHD.

Bone marrow transplantation·2026
Same author

Staphylococcal proliferation on skin models to investigate novel anti-infective treatments against dysbiosis.

Bioengineering & translational medicine·2026
Same author

The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic Context.

HLA·2026
Same author

HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Bone marrow transplantation·2026
Same author

Mechanochemical Methods for Amide Bond Formation.

Chemical reviews·2026

Related Experiment Video

Updated: Dec 29, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.5K

Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).

Alexander H Schmidt1,2,3, Jürgen Sauter1, Daniel M Baier1

  • 1DKMS, Tübingen, Germany.

International Journal of Immunogenetics
|February 9, 2020
PubMed
Summary
This summary is machine-generated.

This review explores stem cell donor registry work, focusing on immunogenetics and population genetics. It details non-HLA gene typing, donor characteristics, and novel allele identification.

Keywords:
CMVDKMSHLAKIRMICA/MICBdonor registryunrelated hematopoietic stem cell transplantation

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K
Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

15.7K

Related Experiment Videos

Last Updated: Dec 29, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.5K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K
Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

15.7K

Area of Science:

  • Immunogenetics
  • Population Genetics
  • Hematology

Background:

  • DKMS is a major stem cell donor registry with over 9 million donors worldwide.
  • Donor registry operations intersect significantly with immunogenetics and population genetics.

Purpose of the Study:

  • To review the immunogenetic and population genetic aspects of stem cell donor registry work, using DKMS as a case study.
  • To focus on specific areas including non-HLA gene typing, donor characteristics, and novel allele identification in the second part of the review.

Main Methods:

  • Review of scientific literature and DKMS registry data.
  • Analysis of donor typing for non-HLA genes.
  • Examination of factors influencing donation probabilities (age, gender, CMV status).
  • High-throughput typing for identifying novel HLA, KIR, and MIC alleles.
  • Overview of Collaborative Biobank activities and pharmacogenetics within the registry.

Main Results:

  • Detailed examination of non-HLA gene typing methodologies in donor registries.
  • Insights into how donor demographics (age, gender) and serostatus (CMV) affect donation likelihood.
  • Identification and characterization of novel HLA, KIR, and MIC genetic variants.
  • Description of the role and scope of the Collaborative Biobank.
  • Exploration of pharmacogenetic applications in donor registries.

Conclusions:

  • Stem cell donor registries like DKMS are rich sources for immunogenetic and population genetic research.
  • Understanding donor genetics and characteristics is crucial for optimizing donor selection and registry efficiency.
  • High-throughput technologies are advancing the discovery of genetic diversity within donor populations.
  • Biobanking and pharmacogenetics offer further avenues for leveraging donor data for scientific advancement and personalized medicine.